Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianlie Weitong granules in type III chronic prostatitis
CTR20150387Phase 3Suspended
- Sponsor
- Jilin Province Innovative Pharmaceutical Public Service Platform
- Start
- Jun 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of qianlieweitong granules in chronic prostatitis (CP), sponsored by Jilin Province Innovative Pharmaceutical Public Service Platform. Started Jun 2015; status: suspended.
02
Drugs
qianlieweitong granules
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20150387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150387.